BR9917528A - Tratamento de sìndrome de dismorfia/dimetábolica associada a hiv - Google Patents

Tratamento de sìndrome de dismorfia/dimetábolica associada a hiv

Info

Publication number
BR9917528A
BR9917528A BR9917528-2A BR9917528A BR9917528A BR 9917528 A BR9917528 A BR 9917528A BR 9917528 A BR9917528 A BR 9917528A BR 9917528 A BR9917528 A BR 9917528A
Authority
BR
Brazil
Prior art keywords
hiv
treatment
hadds
dimetabolic
dysmorphia
Prior art date
Application number
BR9917528-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Ramon A Torres
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP10372070A priority Critical patent/JP2000191549A/ja
Priority to CA002257804A priority patent/CA2257804A1/en
Application filed by Applied Research Systems filed Critical Applied Research Systems
Priority to BR9917528-2A priority patent/BR9917528A/pt
Publication of BR9917528A publication Critical patent/BR9917528A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BR9917528-2A 1998-12-28 1999-06-25 Tratamento de sìndrome de dismorfia/dimetábolica associada a hiv BR9917528A (pt)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP10372070A JP2000191549A (ja) 1998-12-28 1998-12-28 Ｈｉｖに関連した異形症／代謝不全症候群の治療
CA002257804A CA2257804A1 (en) 1998-12-28 1999-01-05 Treatment of hiv-associated dysmorphia/dysmetabolic syndrome
BR9917528-2A BR9917528A (pt) 1998-12-28 1999-06-25 Tratamento de sìndrome de dismorfia/dimetábolica associada a hiv

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10372070A JP2000191549A (ja) 1998-12-28 1998-12-28 Ｈｉｖに関連した異形症／代謝不全症候群の治療
CA002257804A CA2257804A1 (en) 1998-12-28 1999-01-05 Treatment of hiv-associated dysmorphia/dysmetabolic syndrome
BR9917528-2A BR9917528A (pt) 1998-12-28 1999-06-25 Tratamento de sìndrome de dismorfia/dimetábolica associada a hiv

Publications (1)

Publication Number Publication Date
BR9917528A true BR9917528A (pt) 2002-07-23

Family

ID=32073587

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9917528-2A BR9917528A (pt) 1998-12-28 1999-06-25 Tratamento de sìndrome de dismorfia/dimetábolica associada a hiv

Country Status (3)

Country Link
JP (1) JP2000191549A (ja)
BR (1) BR9917528A (ja)
CA (1) CA2257804A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001028532A2 (en) * 1999-10-19 2001-04-26 Kain Kevin C Methods and compositions for predicting, diagnosing and treating lipodystrophy

Also Published As

Publication number Publication date
CA2257804A1 (en) 2000-07-05
JP2000191549A (ja) 2000-07-11

Similar Documents

Publication Publication Date Title
PE20011363A1 (es) Analogos del peptido-1 semejante a glucagon
MY121291A (en) Fracture healing using pthrp analogs
BR0211062A (pt) Combinações para o tratamento de distúrbios inflamatórios
DE60327771D1 (de) Glp-1 und behandlungsmethode für diabetes
BR0317747A (pt) Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave
ATE450269T1 (de) Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten
WO2003000242A3 (en) Method for the treatment of lymphedema using guaifenesin
HK1123741A1 (en) Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders (dextromethorphan)(quinidine)
DE69841907D1 (de) Zusammensetzungen enthaltend Capsaicin oder Capsaicin Analoge und ein Anästhetikum
BR9812484A (pt) Terapia combinada para erradicação de hcv-rna detectável em pacientes com infecção crÈnica por hepatite c
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
ATE112684T1 (de) Verwendung von igf-ii zur behandlung von knochenkrankheiten.
ATE414522T1 (de) Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure
EA200600817A1 (ru) Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты)
KR960000921A (ko) 칼시토닌 유도체 및 그 용도
BR9917528A (pt) Tratamento de sìndrome de dismorfia/dimetábolica associada a hiv
PT1251850E (pt) Utilizacao de uma preparacao de combinacao na terapia do cancro
NO982935D0 (no) Hyaluronsyre reseptor bindende middel og anvendelse derav
CO5160259A1 (es) Interferon alfa pegilado en la terapia contra el hiv
BR0318426A (pt) uso de hormÈnio de crescimento humano em atrofia multissistêmica
姜爱平 et al. Clinical effect of acupuncture treatment in 109 cases of knee osteoarthritis
US20110178012A1 (en) Use of human chorionic gonadotropin orally for the treatment of overweight (obesity) associated with high blood tension, non-insulin-dependant diabetes, hypercholesterolemia, dyslipidemias and lipodystrophy.
ATE324898T1 (de) Behandlung von hiv infektionen
BR9812466A (pt) Uso de ifn-alfa e amantadina para o tratamento da hepatite c crÈnica
BR0009646A (pt) Terapia de melanoma

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL)

Free format text: ALTERADA A SEDE DO TITULAR CONFORME REQUERIDA ATRAVES DA PETICAO NO 012357/RJ DE 11/04/2000.

B25A Requested transfer of rights approved

Owner name: LABORATOIRES SERONO S.A. (CH)

Free format text: TRANSFERIDO DE: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10 (VIII) E 13 DA LPI.

B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.